Erik

Introduction In the world of healthcare marketing and communication, collecting e-permission from HCPs is a crucial step in building valuable relationships and fostering collaboration. Opt-ins, which signify a doctor's willingness...

Introduction In the rapidly evolving landscape of healthcare and pharmaceuticals, the need for accurate and up-to-date information has never been greater. Medical Science Liaisons (MSLs) are crucial players in bridging...

Introduction The landscape of healthcare marketing is undergoing a transformative shift from traditional push strategies to more (digital) personalized and engaging pull approaches. A key driving force behind this evolution...

Introduction Phase 3 of the development of a new drug is generally considered a suitable and strategic time to start collecting opt-ins from doctors. Phase 3 clinical trials are a...

Introduction Disease awareness is a cornerstone of proactive healthcare management, enabling early diagnosis, informed decision-making and improved patient outcomes. In the digital age, harnessing the expertise and influence of healthcare...

Introduction The journey of developing a new pharmaceutical drug is a complex and intricate process that involves rigorous research, clinical trials and regulatory approvals. Amidst these multifaceted stages, there comes...

Introduction The pre-marketing phase of a prescription drug is a critical juncture that sets the stage for a successful product launch and early adoption. One key element during this phase...

Curious? Schedule a meeting with us. Tip: involve your colleagues from other departments within your company. In this way we can instantly answer questions and provide clarity from various points...

A CRM application and a consent management platform are complementary solutions, developed with a different purpose. Every Pharma & life sciences company should be aware that a consent management platform...